TY - JOUR
T1 - Synopsis of the 2017 U.S. Department of veterans affairs/ U.S. Department of defense clinical practice guideline
T2 - Management of type 2 diabetes mellitus
AU - Conlin, Paul R.
AU - Colburn, Jeffrey
AU - Aron, David
AU - Pries, Rose Mary
AU - Tschanz, Mark P.
AU - Pogach, Leonard
N1 - Publisher Copyright:
© 2017 American College of Physicians.
PY - 2017/11/7
Y1 - 2017/11/7
N2 - Description: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. Methods: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included a multidisciplinary panel of practicing clinician stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions in collaboration with the ECRI Institute, which systematically searched and evaluated the literature through June 2016, developed an algorithm, and rated recommendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis summarizes key features of the guideline in 7 areas: patient-centered care and shared decision making, glycemic biomarkers, hemoglobin A1c target ranges, individualized treatment plans, outpatient pharmacologic treatment, glucose targets for critically ill patients, and treatment of hospitalized patients.
AB - Description: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. Methods: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline development effort that included a multidisciplinary panel of practicing clinician stakeholders and conformed to the Institute of Medicine's tenets for trustworthy clinical practice guidelines. The guideline panel developed key questions in collaboration with the ECRI Institute, which systematically searched and evaluated the literature through June 2016, developed an algorithm, and rated recommendations by using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) system. Recommendations: This synopsis summarizes key features of the guideline in 7 areas: patient-centered care and shared decision making, glycemic biomarkers, hemoglobin A1c target ranges, individualized treatment plans, outpatient pharmacologic treatment, glucose targets for critically ill patients, and treatment of hospitalized patients.
UR - http://www.scopus.com/inward/record.url?scp=85033585922&partnerID=8YFLogxK
U2 - 10.7326/M17-1362
DO - 10.7326/M17-1362
M3 - Review article
C2 - 29059687
AN - SCOPUS:85033585922
SN - 0003-4819
VL - 167
SP - 655
EP - 663
JO - Annals of Internal Medicine
JF - Annals of Internal Medicine
IS - 9
ER -